Skip to content
StockMarketAgent
Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

TLV/GEFR stock hub

TLV/GEFR has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

TLV/GEFRis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
349.3M
Tel Aviv Stock Exchange
Market data

Price

Recent price action with selectable time range.

TLV/GEFRTLV/GEFR
—
Loading chart…
In the news

Latest news · TLV/GEFR

Recent company headlines from major financial publishers.

Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Loading
—
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window—
EPS estimate—
Revenue estimate—
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/En/a
P25 n/aP50 n/aP75 n/a
ROE-5.2
P25 n/aP50 n/aP75 n/a
ROIC-3
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All TLV/GEFR market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
176
Groups with data
11
Currency
ILS
Showing 176 of 176 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

19
MetricValue
Country
Israel
Country code
IL
Employees
6
Employees Change
0%
Employees Change Percent
0
Enterprise value
ILA 419.7M
Exchange
Tel Aviv Stock Exchange
Financial currency
ILS
First seen
2026-05-10
Industry
Biotechnology
Isin
IL0011181166
Last refreshed
2026-05-10
Market cap
ILA 349.3M
Price
ILA 84.9
Price currency
ILA
Rev Per Employee
13,000x
Sector
Healthcare
Sic
5912
Symbol
tlv/GEFR

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

6
MetricValue
Earnings Yield
-1.47%
EV Earnings
-81.94x
EV/FCF
-24.26x
FCF yield
-4.95%
P/B ratio
2.41x
P/S ratio
4,477.74x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

16
MetricValue
Gross margin
100%
Gross Profit
ILA 78,000
Gross Profit Growth
-40.46%
Gross Profit Growth Q
-24%
Gross Profit Growth5 Y
-45.62%
Net Income
ILA -5.1M
Net Income Growth Quarters
1%
Net Income Growth Years
0%
Pretax Margin
-8,821.79%
Profit Per Employee
ILA -853,667
ROA
-2.41
Roa5y
-17.51
ROCE
-2.8
ROE
-5.24
Roe5y
-50.76
ROIC
-2.97

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

11
MetricValue
Cagr1y
41.53%
Cagr3y
29.82%
Cagr5y
4.09%
EPS Growth Quarters
1
EPS Growth Years
3
Revenue Growth
-40.46x
Revenue Growth Q
-24x
Revenue Growth Quarters
1x
Revenue Growth Years
1x
Revenue Growth3 Y
9.14x
Revenue Growth5 Y
-56.55x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

19
MetricValue
Asset Turnover
ILA 0
Assets
ILA 264.3M
Cash
ILA 6.5M
Current Assets
ILA 20.4M
Current Liabilities
ILA 11.2M
Debt
ILA 53.6M
Debt Equity
ILA 0.37
Debt FCF
ILA -3.1
Equity
ILA 145.2M
Interest Coverage
-1.48
Liabilities
ILA 119.1M
Long Term Assets
ILA 243.9M
Long Term Liabilities
ILA 107.9M
Net Cash
ILA -47.1M
Net Cash By Market Cap
ILA -13.49
Net Debt Equity
ILA 0.32
Tangible Book Value
ILA 115.4M
Tangible Book Value Per Share
ILA 0.35
WACC
2.63

Liquidity

Current-asset coverage and working-capital efficiency metrics.

5
MetricValue
Current ratio
1.82
Net Working Capital
ILA 10M
Quick ratio
0.62
Working Capital
ILA 9.2M
Working Capital Turnover
ILA 0

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-49.78%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

36
MetricValue
1Y total return
41.5%
200-day SMA
78.12
3Y total return
118.81%
50-day SMA
82.76
50-day SMA vs 200-day SMA
50over200
5Y total return
22.16%
All Time High
639
All Time High Change
-86.71%
All Time High Date
2019-04-24
All Time Low
20.6
All Time Low Change
312.14%
All Time Low Date
2022-09-13
ATR
2.3
Beta
-0.42
Beta1y
-0.13
Beta2y
-0.06
Ch YTD
5.47
High
85.5
High52
89.4
High52 Date
2026-03-02
High52ch
-5.03%
Low
84.1
Low52
47.4
Low52 Date
2025-05-26
Low52ch
79.11%
Ma50ch
2.58%
Price vs 200-day SMA
8.69%
RSI
55.54
RSI Monthly
63.85
RSI Weekly
46.43
Sharpe ratio
1.25x
Sortino ratio
2.24
Total Return
-49.78%
Tr YTD
5.47
Tr1w
-0.93%
Tr3m
6.93%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
ILA -7.1M
Operating margin
-9,070.5

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
264,193,095%
Net Borrowing
7,094,000
Shares Insiders
35.77%
Shares Institutions
23.06%
Shares Out
411,382,879
Shares Qo Q
162.4%
Shares Yo Y
49.78%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

54
MetricValue
Adjusted FCF
ILA -17.4M
Average Volume
228,743.25x
Bv Per Share
0.37
CAPEX
ILA -12,000
Ch1w
-0.93
Ch1y
41.5
Ch3m
6.93
Ch3y
118.8
Ch5y
22.16
Ch6m
1.8
Change
-0.7%
Change From Open
-0.7
Close
85.5
Days Gap
0
Depreciation Amortization
242,000
Dollar Volume
5,002,223.1
Earnings Date
2026-05-20
EBIT
ILA -7.1M
EBITDA
ILA -6.8M
EPS
ILA -0.02
F Score
0
FCF
ILA -17.3M
FCF EV Yield
-4.12x
FCF Per Share
ILA -0.04
Financing CF
7,094,000
Fiscal Year End
December
Founded
1,999
Goodwill
6,510,000
Income Tax
ILA -1.6M
Investing CF
2,199,000
Is Primary Listing
1
Last Earnings Date
2026-03-15
Last Report Date
2025-12-31
Last Split Date
2021-02-07
Last Split Type
Reverse
Ma150
80.57
Ma150ch
5.38%
Ma20
83.27
Ma20ch
1.96%
Net CF
-7,996,000
Next Earnings Date
2026-05-20
Open
85.5
Position In Range
57.14
Ppne
768,000
Price Date
2026-05-08
Ptbv Ratio
3.03
Relative Volume
0.26x
Revenue
78,000x
SBC By Revenue
178.21x
Share Based Comp
139,000
Tax By Revenue
-2,110.26x
Tr6m
1.8%
Volume
58,919
Z Score
0.39
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does TLV/GEFR pay a dividend?

Capital-return profile for this ticker.

Performance

TLV/GEFR stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+41.5%
S&P 500 1Y: n/a
3Y total return
+118.8%
S&P 500 3Y: n/a
5Y total return
+22.2%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns TLV/GEFR?

Insider, institutional, and short-interest positioning.

Institutional ownership
+23.1%
Share of float held by funds and institutions
Insider ownership
+35.8%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+49.8%
Negative means the company is buying back shares.
Technical

TLV/GEFR momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
55.5
Neutral momentum band
Price vs 200-day MA
+8.7%
50/200-day relationship not available
Beta (5Y)
-0.42
Less volatile than the market
Sharpe ratio
1.25
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About TLV/GEFR

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tlv/GEFR stock rating?

tlv/GEFR is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tlv/GEFR analysis?

The full report lives at /stocks/tlv/GEFR/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tlv/GEFR?

The latest report frames tlv/GEFR around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tlv/GEFR page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.